Modus Therapeutics Holding AB(SE:MODTX)
kr 0.16+0.00 (+1.25%)
SE:MODTX
Modus Therapeutics Holding AB financials statements
kr 0.16
At close:+0.00 (+1.25%)
Want to see SE:MODTX full AI Analyst Report?
Modus Therapeutics Holding AB (MODTX) Ratios
0 Followers
Modus Therapeutics Holding AB Ratios
SE:MODTX's free cash flow for Q2 2026 was kr-3.54M. For the 2026 fiscal year, SE:MODTX's free cash flow was increased by kr0.00 and operating cash flow was kr-3.54M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.51 | 1.76 | 8.47 | 0.81 | 3.87 |
| Quick Ratio | 3.51 | 1.76 | 8.47 | 0.81 | 3.87 |
| Cash Ratio | 3.15 | 1.59 | 8.08 | 0.75 | 3.78 |
| Solvency Ratio | -5.13 | -5.66 | -0.63 | -0.02 | -3.79 |
| Operating Cash Flow Ratio | -5.00 | -5.34 | -7.07 | -1.57 | -2.95 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | -1.89 | 0.00 |
| Net Current Asset Value | kr 9.07M | kr 2.08M | kr 17.63M | kr -2.63M | kr 15.69M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 1.02 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | -4.45 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 1.29 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.40 | 2.29 | 1.13 | -4.36 | 1.35 |
| Debt Service Coverage Ratio | -45.30 | 0.00 | 0.00 | -1.52 | -20691.00 |
| Interest Coverage Ratio | -45.30 | 0.00 | -10.96 | -57.34 | -20690.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.26 | 0.00 |
| Interest Debt Per Share | 0.01 | 0.00 | 0.08 | 0.73 | 0.00 |
| Net Debt to EBITDA | 0.63 | 0.28 | -9530.00 | -0.06 | 1.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 102.08% | 98.15% | 109.12% | 101.74% | 100.00% |
| Return on Assets (ROA) | -146.17% | -318.28% | -89.30% | -162.54% | -97.64% |
| Return on Equity (ROE) | -204.42% | -727.42% | -101.22% | 708.70% | -131.50% |
| Return on Capital Employed (ROCE) | -200.26% | -741.13% | -92.76% | 696.56% | -131.50% |
| Return on Invested Capital (ROIC) | -200.26% | -741.13% | -92.76% | -201.78% | -131.50% |
| Return on Tangible Assets | -146.17% | -318.28% | -89.30% | -162.54% | -97.64% |
| Earnings Yield | -97.36% | -23.90% | -57.96% | -40.78% | -44.00% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.29 | -0.41 | -0.94 | -1.35 | -1.30 |
| Free Cash Flow Per Share | -0.29 | -0.41 | -0.94 | -1.35 | -1.30 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | -1.89 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -94.91% | -22.57% | -54.03% | -48.36% | -34.19% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.01 | -4.21 | -1.73 | -2.45 | -2.27 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.10 | 30.44 | 1.75 | -17.38 | 2.99 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.05 | -4.43 | -1.85 | -2.07 | -2.93 |
| Price-to-Operating Cash Flow Ratio | -1.05 | -4.43 | -1.85 | -2.07 | -2.93 |
| Price-to-Earnings Growth (PEG) Ratio | 0.03 | 0.07 | 0.15 | 0.08 | -0.01 |
| Enterprise Value Multiple | -0.42 | -3.83 | 5908.15 | -2.55 | -1.28 |
| Enterprise Value | 7.67M | 60.67M | 11.82M | 45.99M | 26.38M |
| EV to EBITDA | -0.42 | -3.83 | 5908.15 | -2.55 | -1.28 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.42 | -4.13 | -0.71 | -2.12 | -1.64 |
| EV to Operating Cash Flow | -0.42 | -4.13 | -0.71 | -2.12 | -1.64 |
| Tangible Book Value Per Share | 0.14 | 0.06 | 1.00 | -0.16 | 1.27 |
| Shareholders’ Equity Per Share | 0.14 | 0.06 | 1.00 | -0.16 | 1.27 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.30 | -0.43 | -1.01 | -1.14 | -1.67 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.02 | 0.98 | 1.09 | 1.02 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.00 | 0.94 | 0.93 | 1.21 | 0.78 |
Currency in SEK
